{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:58Z","timestamp":1792724998702,"version":"4.5.0"},"reference-count":275,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.phymed.2025.157652","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:11:44Z","timestamp":1764781904000},"page":"157652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Natural compound-nanoparticle therapies for breast cancer: A review from 2018-2025"],"prefix":"10.1016","volume":"150","author":[{"given":"Xiaoyue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7329-7314","authenticated-orcid":false,"given":"Sun","family":"Xiujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-5271","authenticated-orcid":false,"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157652_bib0001","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Abu Samaan","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2025.157652_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120789","article-title":"Paclitaxel's mechanistic and clinical effects on breast cancer","volume":"9","author":"Abu Samaan","year":"2019","journal-title":"Biomolecules."},{"key":"10.1016\/j.phymed.2025.157652_bib0003","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/21691401.2017.1376675","article-title":"Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment","volume":"46","author":"Afsharzadeh","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.phymed.2025.157652_bib0004","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijbiomac.2019.01.142","article-title":"Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles","volume":"128","author":"Ahmad","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.157652_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152883","article-title":"Apoptosis induced by luteolin in breast cancer: mechanistic and therapeutic perspectives","volume":"59","author":"Ahmed","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0006","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1021\/acs.molpharmaceut.9b00355","article-title":"Zeta potential changing polyphosphate nanoparticles: a promising approach to overcome the mucus and epithelial barrier","volume":"16","author":"Akkus","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2025.157652_bib0007","first-page":"15","article-title":"Photolytic controlled release formulation of methotrexate loaded in Chitosan\/TiO(2) nanoparticles for breast cancer","author":"Al-Nemrawi","year":"2022","journal-title":"Pharmaceuticals. (Basel)"},{"key":"10.1016\/j.phymed.2025.157652_bib0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fct.2017.03.024","article-title":"Resveratrol as MDR reversion molecule in breast cancer: an overview","volume":"103","author":"Alamolhodaei","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2025.157652_bib0105","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.2147\/IJN.S303832","article-title":"Novel strategies for disrupting cancer-cell functions with mitochondria-targeted antitumor drug-loaded nanoformulations","volume":"16","author":"Allemailem","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122126","article-title":"Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells","volume":"298","author":"Alizadeh Zeinabad","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157652_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver. Dis."},{"key":"10.1016\/j.phymed.2025.157652_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189109","article-title":"Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor","volume":"1879","author":"Aloss","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2197370","article-title":"Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic","volume":"12","author":"Alvarez","year":"2023","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.phymed.2025.157652_bib0013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2025.157652_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0015","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/med.21971","article-title":"Nano)platforms in breast cancer therapy: drug\/gene delivery, advanced nanocarriers and immunotherapy","volume":"43","author":"Ashrafizadeh","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2025.157652_bib0016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1158\/1078-0432.CCR-22-2191","article-title":"Triple-negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine","volume":"29","author":"Asleh","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49446-x","article-title":"pH\/redox responsive size-switchable intelligent nanovehicle for tumor microenvironment targeted DOX release","volume":"13","author":"Badparvar","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2025.157652_bib0018","first-page":"1","article-title":"Toxicity of nanoparticles and an overview of current experimental models","volume":"20","author":"Bahadar","year":"2016","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.phymed.2025.157652_bib0019","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jamaoncol.2020.2194","article-title":"The conundrum of the association of chemotherapy with survival outcomes among elderly patients with curable luminal breast cancer","volume":"6","author":"Battisti","year":"2020","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00018-022-04551-4","article-title":"Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action","volume":"79","author":"Behroozaghdam","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0021","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.phymed.2025.157652_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/878134","article-title":"Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer","volume":"2015","author":"Bimonte","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2025.157652_bib0023","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.7150\/thno.37543","article-title":"EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX nanoparticles","volume":"10","author":"Bort","year":"2020","journal-title":"Theranostics."},{"key":"10.1016\/j.phymed.2025.157652_bib0024","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1007\/s00210-024-03082-y","article-title":"Application of nanoparticles in breast cancer treatment: a systematic review","volume":"397","author":"Bourang","year":"2024","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0025","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0026","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update","volume":"37","author":"Burstein","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0027","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.2147\/IJN.S218085","article-title":"Manganese oxide nanoparticles As MRI contrast agents In tumor multimodal imaging and therapy","volume":"14","author":"Cai","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0028","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0029","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2019.01.041","article-title":"Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo","volume":"70","author":"Cao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0030","first-page":"1499","article-title":"Engineered exosome-mediated Near-Infrared-II region V(2)C quantum dot delivery for nucleus-target low-temperature photothermal therapy","volume":"13","author":"Cao","year":"2019","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0031","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0032","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canlet.2006.05.005","article-title":"Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells","volume":"247","author":"Casado","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157652_bib0033","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-014-2420-1","article-title":"A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer","volume":"73","author":"Chan","year":"2014","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0034","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc2816","article-title":"Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines","volume":"13","author":"Chen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phymed.2025.157652_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119518","article-title":"Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer","volume":"290","author":"Chen","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phymed.2025.157652_bib0036","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1021\/acsami.4c13433","article-title":"Mitochondria-targeted icaritin nanoparticles induce immunogenic cell death in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2025","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0037","first-page":"12","article-title":"Nanotechnology-based biopolymeric oral delivery platforms for advanced cancer treatment","author":"Chivere","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2025.157652_bib0038","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/1871520617666170327152026","article-title":"Anti-cancer effect of cyanidin-3-glucoside from Mulberry via caspase-3 cleavage and DNA fragmentation in vitro and in vivo","volume":"17","author":"Cho","year":"2017","journal-title":"AntiCancer Agents Med. Chem."},{"key":"10.1016\/j.phymed.2025.157652_bib0039","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1093\/carcin\/bgs248","article-title":"Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: implications for breast cancer chemoprevention in at-risk populations","volume":"33","author":"Chun","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2025.157652_bib0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jat.3800","article-title":"Cytotoxic and proinflammatory responses induced by ZnO nanoparticles in in vitro intestinal barrier","volume":"39","author":"Colombo","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.phymed.2025.157652_bib0041","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1039\/D0NP00092B","article-title":"Metabolic engineering for plant natural products biosynthesis: new procedures, concrete achievements and remaining limits","volume":"38","author":"Courdavault","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phymed.2025.157652_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092147","article-title":"Dietary curcumin: correlation between bioavailability and health potential","volume":"11","author":"Dei Cas","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2025.157652_bib0043","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/S0140-6736(24)00425-2","article-title":"Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment","volume":"403","author":"Delaloge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2025.157652_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.175711","article-title":"Cobalt nanoparticles attenuate microplastic-induced vascular endothelial injury via Nrf2 pathway activation","volume":"951","author":"Deng","year":"2024","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.phymed.2025.157652_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121192","article-title":"Dextran-based micelles for combinational chemo-photodynamic therapy of tumors via in vivo chemiluminescence","volume":"319","author":"Ding","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phymed.2025.157652_bib0046","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/mp800032f","article-title":"Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution","volume":"5","author":"Dobrovolskaia","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2025.157652_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156617","article-title":"Diabetic wound healing breakthrough: theaflavin-3, 3\u2032-digallate nanoparticles@hydrogel activates the TGF-\u03b21\/SMAD3 pathway","volume":"141","author":"Dong","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020445","article-title":"Nasal tumor vaccination protects against lung tumor development by induction of resident effector and memory anti-tumor immune responses","volume":"15","author":"Donkor","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020177","article-title":"Recent trends in curcumin-containing inorganic-based nanoparticles intended for In vivo cancer therapy","volume":"16","author":"Dourado","year":"2024","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.112831","article-title":"Large-capacity DNA vectors based on rolling circle amplification with multivalent aptamers delivery copper sulfide for the synergistic treatment of cancer through chemo\/photothermal\/chemodynamic therapy in vitro","volume":"265","author":"Du","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.phymed.2025.157652_bib0051","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijbiomac.2021.06.085","article-title":"Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model","volume":"185","author":"Elsayed","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.157652_bib0052","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/00003088-200342110-00002","article-title":"Pharmacokinetics of L-carnitine","volume":"42","author":"Evans","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phymed.2025.157652_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117463","article-title":"A review on anti-cancer properties of Quercetin in breast cancer","volume":"248","author":"Ezzati","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020407","article-title":"PEGylated chitosan nanoparticles encapsulating ascorbic acid and oxaliplatin exhibit dramatic apoptotic effects against breast cancer cells","volume":"14","author":"Fahmy","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0056","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1021\/acsnano.2c12217","article-title":"Engineering MMP-2 activated nanoparticles carrying B7-H3 bispecific antibodies for ferroptosis-enhanced glioblastoma Immunotherapy","volume":"17","author":"Fan","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042144","article-title":"Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer","volume":"23","author":"Farghadani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0058","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.msec.2016.03.023","article-title":"The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: different administration routes","volume":"63","author":"Fasehee","year":"2016","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"10.1016\/j.phymed.2025.157652_bib0059","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1039\/C5CS00699F","article-title":"In vivo degeneration and the fate of inorganic nanoparticles","volume":"45","author":"Feliu","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phymed.2025.157652_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102582","article-title":"Curcumin encapsulation in functional PLGA nanoparticles: a promising strategy for cancer therapies","volume":"300","author":"Feltrin","year":"2022","journal-title":"Adv. Colloid. Interface Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107650","article-title":"Traditional application and modern pharmacological research of Artemisia annua L","volume":"216","author":"Feng","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2025.157652_bib0062","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105974","article-title":"Effects and mechanisms of dietary bioactive compounds on breast cancer prevention","volume":"178","author":"Ganesan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111829","article-title":"Targeting engineered nanoparticles for breast cancer therapy","volume":"13","author":"Ganesan","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nyas.13446","article-title":"Molecular targets of vitexin and isovitexin in cancer therapy: a critical review","volume":"1401","author":"Ganesan","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010013","article-title":"Telomerase inhibitors from natural products and their anticancer potential","volume":"19","author":"Ganesan","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0067","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11427-023-2499-2","article-title":"Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway","volume":"67","author":"Ganesan","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0068","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.drudis.2016.10.014","article-title":"miRNA nanotherapeutics for cancer","volume":"22","author":"Ganju","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phymed.2025.157652_bib0069","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2025.157652_bib0070","first-page":"1","article-title":"Graphene quantum dots for breast cancer treatment","author":"GLG","year":"2025","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.phymed.2025.157652_bib0071","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phymed.2025.157652_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111959","article-title":"Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo","volume":"132","author":"Gong","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0073","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1021\/acsami.7b15165","article-title":"Transferrin-copper nanocluster-doxorubicin nanoparticles as targeted theranostic cancer nanodrug","volume":"10","author":"Goswami","year":"2018","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0074","first-page":"194","article-title":"Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment","volume":"67","author":"Greenlee","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157652_bib0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phymed.2025.157652_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051546","article-title":"Redox-responsive lipidic prodrug nano-delivery system improves antitumor effect of curcumin derivative C210","volume":"15","author":"Guo","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0077","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/mp400514t","article-title":"Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance","volume":"11","author":"Guo","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phymed.2025.157652_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104921","article-title":"Curcumin: an inflammasome silencer","volume":"159","author":"Hasanzadeh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112249","article-title":"Redox sensitive nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine conjugates for CD44-targeted delivery of hydroxychloroquine to combat breast cancer metastasis in vitro and in vivo","volume":"210","author":"He","year":"2022","journal-title":"Colloids. Surf. B Biointerfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112289","article-title":"The other side to the use of active targeting ligands; the case of folic acid in the targeting of breast cancer","volume":"211","author":"Helmy","year":"2022","journal-title":"Colloids. Surf. B Biointerfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0081","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/mnfr.200900146","article-title":"Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7\/adr cells","volume":"54","author":"Hien","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0082","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.accounts.9b00103","article-title":"Nano-cell interactions of non-cationic bionanomaterials","volume":"52","author":"Ho","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0083","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1073\/pnas.1112828109","article-title":"The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo","volume":"109","author":"Hoshino","year":"2012","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.phymed.2025.157652_bib0084","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.7150\/thno.57803","article-title":"An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment","volume":"11","author":"Hsieh","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.phymed.2025.157652_bib0085","article-title":"Targeting a neoantigen derived from a common TP53 mutation","volume":"371","author":"Hsiue","year":"2021","journal-title":"Science (1979)"},{"key":"10.1016\/j.phymed.2025.157652_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144475","article-title":"Hyaluronic acid and ZIF-8 nanocomposites for wound care","volume":"315","author":"Hsu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.157652_bib0087","doi-asserted-by":"crossref","first-page":"28764","DOI":"10.1021\/acsnano.4c07903","article-title":"Harnessing the power of sugar-based nanoparticles: a drug-free approach to enhance immune checkpoint inhibition against glioblastoma and pancreatic cancer","volume":"18","author":"Hsu","year":"2024","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0088","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2025.157652_bib0089","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.18632\/aging.101910","article-title":"Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA\/LKB1\/AMPK pathway","volume":"11","author":"Huang","year":"2019","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.phymed.2025.157652_bib0090","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1021\/acsnano.4c08922","article-title":"Glycopolymeric nanoparticles enrich less immunogenic protein coronas, reduce mononuclear phagocyte clearance, and improve tumor delivery compared to PEGylated nanoparticles","volume":"18","author":"Hulugalla","year":"2024","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0091","first-page":"480","article-title":"Systemic therapy for hormone receptor-positive\/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer","volume":"73","author":"Huppert","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157652_bib0092","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184964","article-title":"Tumor-specific surface marker-independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry","volume":"135","author":"Hyun","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2025.157652_bib0093","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.7150\/thno.49876","article-title":"Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70","volume":"11","author":"Hyun","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.phymed.2025.157652_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119982","article-title":"Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy","volume":"245","author":"Ihsanullah","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157652_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cas.13155","article-title":"Tumor-derived spheroids: relevance to cancer stem cells and clinical applications","volume":"108","author":"Ishiguro","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0096","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072165","article-title":"Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint","volume":"27","author":"Islam","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.phymed.2025.157652_bib0097","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejphar.2014.06.025","article-title":"Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer","volume":"740","author":"Jabbarzadeh Kaboli","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0098","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157652_bib0099","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202500598","article-title":"Nose-to-brain delivery of circular RNA SCMH1-loaded lipid nanoparticles for ischemic stroke therapy","volume":"37","author":"Jia","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cac2.12012","article-title":"Emerging role of deep learning-based artificial intelligence in tumor pathology","volume":"40","author":"Jiang","year":"2020","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.phymed.2025.157652_bib0101","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03935-w","article-title":"Early versus deferred use of CDK4\/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial","author":"Jongbloed","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.157652_bib0102","article-title":"Transferrin-conjugated Docetaxel-PLGA nanoparticles for tumor targeting: influence on MCF-7","volume":"11","author":"Jose","year":"2019","journal-title":"Cell Cycle. Polymers (Basel)"},{"key":"10.1016\/j.phymed.2025.157652_bib0103","article-title":"Correction: jose et al. Transferrin-conjugated Docetaxel-PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle","volume":"15","author":"Jose","year":"2022","journal-title":"Polymers 2019, 11, 1905. Polymers (Basel)"},{"key":"10.1016\/j.phymed.2025.157652_bib0104","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.phymed.2025.157652_bib0106","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10549-009-0612-x","article-title":"Targeting breast stem cells with the cancer preventive compounds curcumin and piperine","volume":"122","author":"Kakarala","year":"2010","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.phymed.2025.157652_bib0107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1742-2094-8-125","article-title":"Curcumin is a potent modulator of microglial gene expression and migration","volume":"8","author":"Karlstetter","year":"2011","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.phymed.2025.157652_bib0108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41568-018-0001-z","article-title":"Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance","volume":"18","author":"Katzenellenbogen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0109","doi-asserted-by":"crossref","DOI":"10.3390\/nu16152392","article-title":"The anticancer effects and therapeutic potential of kaempferol in triple-negative breast cancer","volume":"16","author":"Kaur","year":"2024","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2025.157652_bib0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12943-024-02163-z","article-title":"Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers","volume":"23","author":"Kesharwani","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105892","article-title":"Revisiting inorganic nanoparticles as promising therapeutic agents: a paradigm shift in oncological theranostics","volume":"164","author":"Khan","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0112","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010039","article-title":"Tea polyphenols in promotion of Human health","volume":"11","author":"Khan","year":"2018","journal-title":"Nutrients."},{"key":"10.1016\/j.phymed.2025.157652_bib0113","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000081","article-title":"Aromatase inhibitors: role in postmenopausal breast cancer","volume":"353","author":"Kharb","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.phymed.2025.157652_bib0114","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/IJN.S219042","article-title":"New approaches in breast cancer therapy through green nanotechnology and nano-ayurvedic medicine - pre-clinical and pilot Human clinical investigations","volume":"15","author":"Khoobchandani","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"348","author":"Kim","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2025.157652_bib0116","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1021\/acsnano.9b00326","article-title":"Mucosal immunization with a pH-responsive nanoparticle vaccine induces protective CD8(+) lung-resident memory T cells","volume":"13","author":"Knight","year":"2019","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0117","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/djae056","article-title":"The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis","volume":"116","author":"Kumar","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phymed.2025.157652_bib0118","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijbiomac.2015.12.036","article-title":"A facile green approach to prepare core-shell hybrid PLGA nanoparticles for resveratrol delivery","volume":"84","author":"Kumar","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.157652_bib0119","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/acs.biomac.1c00336","article-title":"Development of HER2-targeting-ligand-modified albumin nanoparticles based on the SpyTag\/SpyCatcher system for photothermal therapy","volume":"22","author":"Lee","year":"2021","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.phymed.2025.157652_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2014.02.006","article-title":"Gold nanoparticles in breast cancer treatment: promise and potential pitfalls","volume":"347","author":"Lee","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157652_bib0121","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/acs.biomac.8b01449","article-title":"Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of Lapatinib to triple-negative breast cancer","volume":"20","author":"Lee","year":"2019","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.phymed.2025.157652_bib0122","doi-asserted-by":"crossref","first-page":"15457","DOI":"10.1021\/acsami.3c17418","article-title":"Carbon-coated iron oxide nanoparticles promote reductive stress-mediated cytotoxic autophagy in drug-induced senescent breast cancer cells","volume":"16","author":"Lewi\u0144ska","year":"2024","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0123","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2217\/nnm-2018-0017","article-title":"The potential of biomimetic nanoparticles for tumor-targeted drug delivery","volume":"13","author":"Li","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.phymed.2025.157652_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2025.157652_bib0125","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1039\/C9MH00014C","article-title":"Ultralong tumor retention of theranostic nanoparticles with short peptide-enabled active tumor homing","volume":"6","author":"Li","year":"2019","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.phymed.2025.157652_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119315","article-title":"Co-delivery of doxorubicin and CRISPR\/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy","volume":"287","author":"Li","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phymed.2025.157652_bib0127","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biochi.2019.03.004","article-title":"Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells","volume":"162","author":"Liang","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.phymed.2025.157652_bib0128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2024.03.006","article-title":"Genetic interactions reveal distinct biological and therapeutic implications in breast cancer","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2025.157652_bib0129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/wnan.1304","article-title":"Pharmacokinetics of metallic nanoparticles","volume":"7","author":"Lin","year":"2015","journal-title":"Wiley. Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2025.157652_bib0130","article-title":"One-step symbiosis of bimetallic peroxides nanoparticles to induce ferroptosis\/cuproptosis and activate cGAS-STING pathway for enhanced tumor immunotherapy","volume":"37","author":"Liu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123111","article-title":"Tunable ion-release biodegradable nanoparticles enhanced pyroptosis for tumor immunotherapy","volume":"317","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157652_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111284","article-title":"Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer","volume":"196","author":"Liu","year":"2020","journal-title":"Colloids. Surf. B Biointerfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0133","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1039\/C6TB01199C","article-title":"Core-shell stability of nanoparticles plays an important role for overcoming the intestinal mucus and epithelium barrier","volume":"4","author":"Liu","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.phymed.2025.157652_bib0134","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.biopha.2017.05.102","article-title":"Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-\u03bab and erk pathway","volume":"92","author":"Liu","year":"2017","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2025.157652_bib0135","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2025.157652_bib0136","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2025.157652_bib0137","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ptr.6201","article-title":"Cyanidin-3-glucoside attenuates the angiogenesis of breast cancer via inhibiting STAT3\/VEGF pathway","volume":"33","author":"Ma","year":"2019","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0138","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400514","article-title":"Engineered cell membrane-coated nanoparticles: new strategies in glioma targeted therapy and immune modulation","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0139","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12905-017-0376-0","article-title":"Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age","volume":"17","author":"Majid","year":"2017","journal-title":"BMC. Womens Health"},{"key":"10.1016\/j.phymed.2025.157652_bib0140","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ptr.7389","article-title":"Curcumin nanoformulations: beneficial nanomedicine against cancer","volume":"36","author":"Maleki Dizaj","year":"2022","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0141","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1039\/C7SM02248D","article-title":"Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery","volume":"14","author":"Malekmohammadi","year":"2018","journal-title":"Soft. Matter."},{"key":"10.1016\/j.phymed.2025.157652_bib0142","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/81.1.230S","article-title":"Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies","volume":"81","author":"Manach","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phymed.2025.157652_bib0143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310737","article-title":"The potential role of epigallocatechin-3-gallate (EGCG) in breast cancer treatment","volume":"24","author":"Mar\u00edn","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0144","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1158\/2159-8290.CD-17-0535","article-title":"Expressed gene fusions as frequent drivers of poor outcomes in hormone receptor-positive breast cancer","volume":"8","author":"Matissek","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2025.157652_bib0145","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40262-018-0664-3","article-title":"Clinical pharmacokinetics of Atypical antipsychotics: an update","volume":"57","author":"Mauri","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phymed.2025.157652_bib0146","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11033-016-3942-x","article-title":"Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells","volume":"43","author":"Minaei","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.phymed.2025.157652_bib0147","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2025.157652_bib0148","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202110305","article-title":"Optimal physicochemical properties of antibody-nanoparticle conjugates for improved tumor targeting","volume":"34","author":"Mittelheisser","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0149","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.apsb.2021.09.024","article-title":"Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: dual targeting of tumor cells and tumor-associated macrophages","volume":"12","author":"Moharil","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.157652_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202414146","article-title":"Self-assembled peptide-derived proteolysis-targeting Chimera (PROTAC) nanoparticles for tumor-targeted and durable PD-L1 degradation in cancer immunotherapy","volume":"64","author":"Moon","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.phymed.2025.157652_bib0151","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/biof.1823","article-title":"The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: a systematic review","volume":"48","author":"Moutabian","year":"2022","journal-title":"Biofactors"},{"key":"10.1016\/j.phymed.2025.157652_bib0152","article-title":"Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy","volume":"5","author":"Mpekris","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phymed.2025.157652_bib0153","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1039\/C5NR04867B","article-title":"Anti-HER2\/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells","volume":"7","author":"Mu","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.phymed.2025.157652_bib0154","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2024.03.047","article-title":"Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy","volume":"369","author":"Mu","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2025.157652_bib0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051744","article-title":"Beneficial properties of green tea catechins","volume":"21","author":"Musial","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0156","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154689","article-title":"Kaempferol with Verapamil impeded panoramic chemoevasion pathways in breast cancer through ROS overproduction and disruption of lysosomal biogenesis","volume":"113","author":"Nandi","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0157","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0158","doi-asserted-by":"crossref","first-page":"17793","DOI":"10.1021\/acsami.6b04403","article-title":"Targeting colorectal cancer stem-like cells with anti-CD133 antibody-conjugated SN-38 nanoparticles","volume":"8","author":"Ning","year":"2016","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0159","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00775-018-1542-z","article-title":"Inorganic nanoparticles in diagnosis and treatment of breast cancer","volume":"23","author":"N\u00fa\u00f1ez","year":"2018","journal-title":"JBIC Journal of Biological Inorganic Chemistry"},{"key":"10.1016\/j.phymed.2025.157652_bib0160","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0161","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0162","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0163","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.612903","article-title":"In vivo efficacy and toxicity of curcumin nanoparticles in breast cancer treatment: a systematic review","volume":"11","author":"Ombredane","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0164","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1496664","article-title":"Mechanism of apigenin against breast cancer stem cells: network pharmacology and experimental validation","volume":"15","author":"Ou","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113991","article-title":"Clinical cancer nanomedicines","volume":"385","author":"Pallares","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2025.157652_bib0166","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7150\/ijbs.18969","article-title":"Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK- HIF-1\u03b1","volume":"13","author":"Pan","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0167","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2575","article-title":"Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells","volume":"12","author":"Paris","year":"2010","journal-title":"Breast. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0168","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","article-title":"Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis","volume":"29","author":"Poggio","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0169","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308241","article-title":"Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors","volume":"36","author":"Qiao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0171","first-page":"15","article-title":"Anthocyanins reduce cell invasion and migration through akt\/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis","author":"Rabelo","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2025.157652_bib0054","first-page":"473","article-title":"Gold-curcumin nanostructure in photo-thermal therapy on breast cancer cell line: 650 and 808 nm diode lasers as light sources","volume":"9","author":"Rahimi-Moghaddam","year":"2019","journal-title":"J. Biomed. Phys. Eng."},{"key":"10.1016\/j.phymed.2025.157652_bib0172","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2024.103204","article-title":"Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics","volume":"329","author":"Rahimkhoei","year":"2024","journal-title":"Adv. Colloid. Interface Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0173","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1039\/D4TB01096E","article-title":"Double-shelled, rattle-architecture covalent organic framework: harnessing morphological manipulation for enhanced synergistic multi-drug chemo-photothermal cancer therapy","volume":"12","author":"Rahmani Khalili","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.phymed.2025.157652_bib0174","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/1097-0142(197901)43:1<66::AID-CNCR2820430109>3.0.CO;2-1","article-title":"Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC)","volume":"43","author":"Rainey","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020279","article-title":"Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma","volume":"14","author":"Ramalho","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0176","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010227","article-title":"Recent advances in mesoporous silica nanoparticle-mediated drug delivery for breast cancer treatment","volume":"15","author":"Rani","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.phymed.2025.157652_bib0177","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157652_bib0178","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41418-021-00862-4","article-title":"Ubiquitination of NF-\u03bab p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance","volume":"29","author":"Ren","year":"2022","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.phymed.2025.157652_bib0179","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1039\/C8CS00162F","article-title":"Liposomes and polymersomes: a comparative review towards cell mimicking","volume":"47","author":"Rideau","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phymed.2025.157652_bib0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pharmthera.2017.10.018","article-title":"Emerging tumor spheroids technologies for 3D in vitro cancer modeling","volume":"184","author":"Rodrigues","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2025.157652_bib0181","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2025.157652_bib0182","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7314\/APJCP.2014.15.2.517","article-title":"PLGA-based nanoparticles as cancer drug delivery systems","volume":"15","author":"Sadat Tabatabaei Mirakabad","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.phymed.2025.157652_bib0183","doi-asserted-by":"crossref","first-page":"22808","DOI":"10.1021\/acsami.6b05099","article-title":"Bypassing protein corona issue on active targeting: zwitterionic coatings dictate specific interactions of targeting moieties and cell receptors","volume":"8","author":"Safavi-Sohi","year":"2016","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0184","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/s41591-024-03093-5","article-title":"AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial","volume":"30","author":"Salim","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.157652_bib0185","article-title":"Curcumin nanoparticle enhances the anticancer effect of cisplatin by inhibiting PI3K\/AKT and JAK\/STAT3 pathway in rat ovarian carcinoma induced by DMBA","volume":"11","author":"Sandhiutami","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0186","doi-asserted-by":"crossref","DOI":"10.3390\/foods13010064","article-title":"Comparative anticancer potential of green tea extract and epigallocatechin-3-gallate on breast cancer spheroids","volume":"13","author":"Santos","year":"2023","journal-title":"Foods."},{"key":"10.1016\/j.phymed.2025.157652_bib0187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-020-00208-2","article-title":"Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer","volume":"7","author":"Schettini","year":"2021","journal-title":"NPJ. Breast. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0188","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41556-024-01446-3","article-title":"Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3","volume":"26","author":"Seehawer","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2025.157652_bib0189","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.biopha.2017.09.059","article-title":"A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer","volume":"95","author":"Shafei","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.phymed.2025.157652_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/21691401.2022.2030746","article-title":"Co-delivery of STAT3 siRNA and methotrexate in breast cancer cells","volume":"50","author":"Shakeran","year":"2022","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.phymed.2025.157652_bib0191","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2022.10.046","article-title":"Responsive shape-shifting nanoarchitectonics and its application in tumor diagnosis and therapy","volume":"352","author":"Shao","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2025.157652_bib0192","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijbiomac.2019.12.064","article-title":"Enzyme immobilization onto the nanomaterials: application in enzyme stability and prodrug-activated cancer therapy","volume":"143","author":"Sharifi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phymed.2025.157652_bib0193","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcis.2025.01.107","article-title":"Nanoparticles (NPs)-mediated silencing of GSTP1 expression to reverse chemoresistance for effective breast cancer therapy","volume":"685","author":"Shen","year":"2025","journal-title":"J. Colloid. Interface Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0194","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(23)00094-6","article-title":"Chemotherapy for early-stage breast cancer: the more the better?","volume":"401","author":"Shen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2025.157652_bib0195","article-title":"Synergistic anticancer strategy targeting ECM stiffness: integration of matrix softening and mechanical signal transduction blockade in primary liver cancers","volume":"12","author":"Shen","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2025.157652_bib0196","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41467-021-27794-4","article-title":"Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.157652_bib0197","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121926","article-title":"Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: synthesis, optimisation and in vitro biological evaluation","volume":"623","author":"Sinai Kunde","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phymed.2025.157652_bib0198","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/1078-0432.CCR-21-4328","article-title":"Estrogen receptor alpha gene amplification is an independent predictor of long-term outcome in postmenopausal patients with endocrine-responsive early breast cancer","volume":"28","author":"Singer","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0199","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.phymed.2025.157652_bib0200","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acsnano.9b08693","article-title":"Tumor targeting by \u03b1(v)\u03b2(3)-integrin-specific lipid nanoparticles occurs via phagocyte hitchhiking","volume":"14","author":"Sofias","year":"2020","journal-title":"ACS. Nano"},{"key":"10.1016\/j.phymed.2025.157652_bib0201","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1038\/s41598-024-51970-3","article-title":"Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells","volume":"14","author":"Solanki","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2025.157652_bib0202","article-title":"Efficient delivery of lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for glioblastoma therapy","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0203","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4155\/tde-2020-0116","article-title":"Evaluation of nanoparticle drug-delivery systems used in preclinical studies","volume":"12","author":"Sreeharsha","year":"2021","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.phymed.2025.157652_bib0204","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-22-0423","article-title":"JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states","volume":"83","author":"Stevens","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0205","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.actbio.2022.12.039","article-title":"Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy","volume":"158","author":"Su","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phymed.2025.157652_bib0206","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41419-023-06342-6","article-title":"Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer","volume":"14","author":"Sudhakaran","year":"2023","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2025.157652_bib0207","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114259","article-title":"Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters","volume":"182","author":"Sudhakaran","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0208","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157652_bib0209","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.phymed.2025.157652_bib0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304966120","article-title":"Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection","volume":"120","author":"Tang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.phymed.2025.157652_bib0211","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000155","article-title":"The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation","volume":"8","author":"Taube","year":"2020","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0212","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051033","article-title":"A review of Curcumin and its derivatives as anticancer agents","volume":"20","author":"Tomeh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0213","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40005-019-00459-7","article-title":"Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment","volume":"50","author":"Tran","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.phymed.2025.157652_bib0214","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.phymed.2025.157652_bib0215","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/am406012g","article-title":"Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy","volume":"6","author":"Vivek","year":"2014","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0216","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phymed.2025.157652_bib0217","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156176","article-title":"GelMA@APPA microspheres promote chondrocyte regeneration and alleviate osteoarthritis via Fgfr2 activation","volume":"137","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0218","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1039\/D1NR00950H","article-title":"Collagenase-loaded pH-sensitive nanocarriers efficiently remodeled tumor stroma matrixes and improved the enrichment of nanomedicines","volume":"13","author":"Wang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.phymed.2025.157652_bib0219","doi-asserted-by":"crossref","first-page":"68864","DOI":"10.18632\/oncotarget.12025","article-title":"Cyanidin-3-o-glucoside directly binds to ER\u03b136 and inhibits EGFR-positive triple-negative breast cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.phymed.2025.157652_bib0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/17425247.2014.951634","article-title":"mPEG-b-PCL\/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer","volume":"12","author":"Wang","year":"2015","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.phymed.2025.157652_bib0221","article-title":"Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0222","doi-asserted-by":"crossref","first-page":"33948","DOI":"10.1021\/acsami.1c09804","article-title":"Oral core-shell nanoparticles embedded in hydrogel microspheres for the efficient site-specific delivery of magnolol and enhanced antiulcerative colitis therapy","volume":"13","author":"Wang","year":"2021","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0223","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2024.01.039","article-title":"A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy","volume":"367","author":"Wang","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2025.157652_bib0224","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109086","article-title":"The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer","volume":"117","author":"Wang","year":"2019","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2025.157652_bib0225","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41417-024-00747-x","article-title":"Recent progress of CDK4\/6 inhibitors\u2019 current practice in breast cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.phymed.2025.157652_bib0226","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111195","article-title":"cRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery","volume":"194","author":"Wang","year":"2020","journal-title":"Colloids. Surf. B Biointerfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0227","article-title":"A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer","volume":"79","author":"Wang","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.phymed.2025.157652_bib0228","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153437","article-title":"Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT\/mTOR signaling pathway","volume":"81","author":"Wu","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.07.034","article-title":"Metabolic intervention liposome for targeting glutamine-addiction of breast cancer","volume":"350","author":"Wu","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2025.157652_bib0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123198","article-title":"Reprogramming peritoneal macrophages with outer membrane vesicle-coated PLGA nanoparticles for endometriosis prevention","volume":"319","author":"Wu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157652_bib0231","first-page":"206","article-title":"A pH-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy","volume":"17","author":"Wu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0232","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.157652_bib0233","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17425247.2016.1205583","article-title":"Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy","volume":"14","author":"Xiao","year":"2017","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.phymed.2025.157652_bib0234","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.apsb.2020.12.018","article-title":"Biological drug and drug delivery-mediated immunotherapy","volume":"11","author":"Xiao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.157652_bib0235","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1021\/acs.jafc.2c06460","article-title":"Comprehensive evaluation of metabolism and the contribution of the hepatic first-pass effect in the bioavailability of glabridin in rats","volume":"71","author":"Xie","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phymed.2025.157652_bib0236","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112567","article-title":"Curcumin combined with photodynamic therapy, promising therapies for the treatment of cancer","volume":"146","author":"Xie","year":"2022","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2025.157652_bib0237","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10510","article-title":"Palmitic acid- and cysteine-functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug","volume":"8","author":"Xie","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.phymed.2025.157652_bib0238","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119769","article-title":"Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model","volume":"235","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157652_bib0239","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156917","article-title":"Ginsenoside F2-modified liposomes delivering FTY720 enhance glioblastoma targeting and antitumor activity via ferroptosis","volume":"144","author":"Xu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0241","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.7150\/thno.39560","article-title":"Probing and enhancing ligand-mediated active targeting of tumors using sub-5 nm ultrafine iron oxide nanoparticles","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics."},{"key":"10.1016\/j.phymed.2025.157652_bib0242","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1248\/bpb.b17-00989","article-title":"Anticancer efficacy of the combination of berberine and PEGylated liposomal doxorubicin in meth A sarcoma-bearing mice","volume":"41","author":"Yahuafai","year":"2018","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.phymed.2025.157652_bib0243","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1007\/s00018-021-03850-6","article-title":"Recent advances in liposome formulations for breast cancer therapeutics","volume":"78","author":"Yang","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0244","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202100349","article-title":"Organic\/inorganic self-assembled hybrid nano-architectures for cancer therapy applications","volume":"22","author":"Yang","year":"2022","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.phymed.2025.157652_bib0245","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0246","doi-asserted-by":"crossref","first-page":"e1603","DOI":"10.1002\/wnan.1603","article-title":"Fluorescent hybrid silica nanoparticles and their biomedical applications","volume":"12","author":"Yang","year":"2020","journal-title":"Wiley. Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.phymed.2025.157652_bib0247","article-title":"Polydopamine nanoparticles targeting ferroptosis mitigate intervertebral disc degeneration via reactive oxygen species depletion, iron ions chelation, and GPX4 ubiquitination suppression","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2025.157652_bib0248","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13046-018-0960-7","article-title":"Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-\u03b2 signaling in breast cancer","volume":"37","author":"Yao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157652_bib0249","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.2147\/IJN.S328135","article-title":"Drug delivery of natural products through nanocarriers for effective breast cancer therapy: a comprehensive review of literature","volume":"16","author":"Yap","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0250","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3109\/07357907.2010.496755","article-title":"A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer","volume":"28","author":"Yardley","year":"2010","journal-title":"Cancer Invest."},{"key":"10.1016\/j.phymed.2025.157652_bib0251","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00604-020-04447-9","article-title":"Experimental and theoretical study for miR-155 detection through resveratrol interaction with nucleic acids using magnetic core-shell nanoparticles","volume":"187","author":"Yazdanparast","year":"2020","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.phymed.2025.157652_bib0252","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-019-1043-x","article-title":"Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA","volume":"18","author":"Ye","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0253","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1470-2045(06)70793-8","article-title":"Emerging use of nanoparticles in diagnosis and treatment of breast cancer","volume":"7","author":"Yezhelyev","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2025.157652_bib0254","doi-asserted-by":"crossref","first-page":"55323","DOI":"10.1021\/acsami.3c11775","article-title":"pH-responsive plasmon-enhanced persistent luminescent ZnGa(2)O(4):cr(3+) nanopomegranate for tumor imaging","volume":"15","author":"Yin","year":"2023","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.phymed.2025.157652_bib0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/21691401.2017.1423495","article-title":"pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer","volume":"46","author":"Yuan","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.phymed.2025.157652_bib0256","article-title":"Pharmacokinetics and tumor delivery of nanoparticles","volume":"83","author":"Yuan","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.phymed.2025.157652_bib0257","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ. Breast. Cancer"},{"key":"10.1016\/j.phymed.2025.157652_bib0258","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.1916395117","article-title":"Organelle-specific targeting of polymersomes into the cell nucleus","volume":"117","author":"Zelmer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.phymed.2025.157652_bib0259","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106825","article-title":"Nano-curcumin attenuates tamoxifen resistance and malignant progression in ER-positive breast cancer cells by inhibiting the PI3K\/AKT\/mTOR signaling pathway","volume":"254","author":"Zhang","year":"2025","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.phymed.2025.157652_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156595","article-title":"Enhancing curcumol delivery through PD-1 targeted nanocarriers: a novel therapeutic approach for prostate cancer","volume":"141","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157652_bib0261","article-title":"Manganese-based tumor immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157652_bib0262","article-title":"A self-disguised nanospy for improving drug delivery efficiency via decreasing drug protonation","volume":"19","author":"Zhang","year":"2023","journal-title":"Small."},{"key":"10.1016\/j.phymed.2025.157652_bib0263","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110768","article-title":"Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles","volume":"111","author":"Zhang","year":"2020","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"10.1016\/j.phymed.2025.157652_bib0264","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","article-title":"Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets","volume":"23","author":"Zhang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phymed.2025.157652_bib0265","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12951-021-01085-y","article-title":"Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.phymed.2025.157652_bib0266","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejps.2011.02.009","article-title":"Curcumin activates wnt\/\u03b2-catenin signaling pathway through inhibiting the activity of GSK-3\u03b2 in APPswe transfected SY5Y cells","volume":"42","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2025.157652_bib0267","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.phymed.2025.157652_bib0268","article-title":"A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2025.157652_bib0269","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","article-title":"Biomacromolecules as carriers in drug delivery and tissue engineering","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.157652_bib0270","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamadermatol.2022.1736","article-title":"Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy: a double-blind, placebo-controlled, phase 2 randomized clinical trial","volume":"158","author":"Zhao","year":"2022","journal-title":"JAMa Dermatol."},{"key":"10.1016\/j.phymed.2025.157652_bib0271","article-title":"Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2025.157652_bib0272","article-title":"Nanoparticles: a hope for the treatment of inflammation in CNS","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0273","doi-asserted-by":"crossref","first-page":"311","DOI":"10.31083\/j.fbl2811311","article-title":"Kaempferol improves breast cancer-related depression through the COX-2\/PGE2 pathway","volume":"28","author":"Zhu","year":"2023","journal-title":"Front. Biosci. (Landmark. Ed)"},{"key":"10.1016\/j.phymed.2025.157652_bib0274","article-title":"Apoptosis induction, a sharp edge of berberine to exert anti-cancer effects, focus on breast, lung, and liver cancer","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157652_bib0275","doi-asserted-by":"crossref","first-page":"444","DOI":"10.18063\/ijb.v7i4.444","article-title":"Using spheroids as building blocks towards 3D bioprinting of tumor microenvironment","volume":"7","author":"Zhuang","year":"2021","journal-title":"Int. J. Bioprint."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325012863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325012863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:23:55Z","timestamp":1768307035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325012863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":275,"alternative-id":["S0944711325012863"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157652","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural compound-nanoparticle therapies for breast cancer: A review from 2018-2025","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157652"}}